[Alpha Biz=(Chicago) Reporter Kim Jisun] The deadline for public purchase subscriptions, which private equity fund (PEF) operators Unison Capital Korea (UCK) and MBK Partners are pushing to acquire management rights of Osstem Implants, is just around the corner on the 24th.
In the financial investment industry on the 20th, "The PEF consortium has already secured more than 60% stake considering the recent movement of institutional and foreign investors."
If the public purchase is successful, the PEF consortium will secure at least 34.3% to a maximum of 90.7%, including Chairman Choi Kyu-ok's stake.
First of all, the public purchase process is going smoothly so far. The stock price of Osstem Implant is currently slightly lower than the open purchase price of 190,000 won.
The stock price, which stood at 186,000 won for the first two weeks after the announcement of the public purchase, is trading at 188,000 won on the same day, four days before the deadline for the public purchase subscription.
The PEF consortium remains cautious, saying, "The final subscription results will not be known until the deadline."
Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)
